Amanote Research
Register
Sign In
New Agents Designed to Fight EBV+ Cancers
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nb2019-040
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
March 27, 2019
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
New Agency Created to Fight Infectious Diseases
BMJ
Cancers Attributable to Infectious Agents: An Ecological Study in Asia
Asian Pacific Journal of Environment and Cancer
Pathogenic Role of Exosomes in Epstein-Barr Virus (EBV)-Associated Cancers
International Journal of Biological Sciences
Applied Microbiology
Evolution
Ecology
Developmental Biology
Cell Biology
Molecular Biology
Systematics
Behavior
Biotechnology
New Policies to Fight Inflation: Sources of Skepticism
Brookings Papers on Economic Activity
Accounting
Management
Economics
Econometrics
Business
Burden of Cancers Attributable to Infectious Agents in Nigeria: 2012–2014
Frontiers in Oncology
Cancer Research
Oncology
Epstein-Barr Virus (EBV) and the Effectiveness of Suberoylanilide Hydroxamic Acid (SAHA) as a Treatment for EBV Infection and Associated Cancers
Advances in Tumor Virology
Intracellular Iron Chelation by a Novel Compound, C7, Reactivates Epstein–Barr Virus (EBV) Lytic Cycle via the ERK-Autophagy Axis in EBV-Positive Epithelial Cancers
Cancers
Cancer Research
Oncology
Pay People to Fight Malaria
Nature
Multidisciplinary
Chiggers : How to Fight Them /
